1. Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced. Issue 4 (26th January 2021) Authors: Zannad, Faiez; Ferreira, João Pedro; Pocock, Stuart J.; Zeller, Cordula; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Hauske, Sibylle Jenny; Brueckmann, Martina; Pfarr, Egon; Schnee, Janet; Wanner, Christoph; Packer, Milton Journal: Circulation Issue: Volume 143:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial. Issue 12 (8th September 2019) Authors: Perkovic, Vlado; Koitka-Weber, Audrey; Cooper, Mark E; Schernthaner, Guntram; Pfarr, Egon; Woerle, Hans J; von Eynatten, Maximilian; Wanner, Christoph Journal: Nephrology dialysis transplantation Issue: Volume 35:Issue 12(2020) Page Start: 2103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease. Issue 1 (3rd May 2021) Authors: Reifsnider, Odette S; Kansal, Anuraag R; Gandhi, Pranav K; Cragin, Lael; Brand, Sarah B; Pfarr, Egon; Fahrbach, Kyle; Ustyugova, Anastasia Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Issue 3 (20th December 2019) Authors: Sone, Hirohito; Kaneko, Tatsuroh; Shiki, Kosuke; Tachibana, Yoshifumi; Pfarr, Egon; Lee, Jisoo; Tajima, Naoko Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of empagliflozin in Japanese patients with type 2 diabetes mellitus: A sub-analysis by body mass index and age of pooled data from three clinical trials. (September 2017) Authors: Shiba, Teruo; Ishii, So; Okamura, Tomoo; Mitsuyoshi, Rika; Pfarr, Egon; Koiwai, Kazuki Journal: Diabetes research and clinical practice Issue: Volume 131(2017) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled. Issue 1 (7th November 2022) Authors: Verma, Subodh; Dhingra, Nitish K.; Butler, Javed; Anker, Stefan D.; Pedro Ferreira, João; Filippatos, Gerasimos; Januzzi, James L.; Lam, Carolyn S.P.; Sattar, Naveed; Pfarr, Egon; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J.; Zannad, Faiez; Packer, Milton Journal: Circulation Issue: Volume 147:Issue 1(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial. Issue 11 (12th March 2019) Authors: Fitchett, David; Inzucchi, Silvio E.; Cannon, Christopher P.; McGuire, Darren K.; Scirica, Benjamin M.; Johansen, Odd Erik; Sambevski, Steven; Kaspers, Stefan; Pfarr, Egon; George, Jyothis T.; Zinman, Bernard Journal: Circulation Issue: Volume 139:Issue 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials. Issue 15 (12th October 2021) Authors: Anker, Stefan D.; Ponikowski, Piotr; Wanner, Christoph; Pfarr, Egon; Hauske, Sibylle; Peil, Barbara; Salsali, Afshin; Ritter, Ivana; Koitka-Weber, Audrey; Brueckmann, Martina; Lindenfeld, JoAnn; Abraham, William T. Journal: Circulation Issue: Volume 144:Issue 15(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials. Issue 15 (16th August 2021) Authors: Anker, Stefan D.; Ponikowski, Piotr; Wanner, Christoph; Pfarr, Egon; Hauske, Sibylle; Peil, Barbara; Salsali, Afshin; Ritter, Ivana; Koitka-Weber, Audrey; Brueckmann, Martina; Lindenfeld, JoAnn; Abraham, William T. Journal: Circulation Issue: Volume 144:Issue 15(2021) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Issue 3 (15th January 2019) Authors: McGuire, Darren K.; Alexander, John H.; Johansen, Odd Erik; Perkovic, Vlado; Rosenstock, Julio; Cooper, Mark E.; Wanner, Christoph; Kahn, Steven E.; Toto, Robert D.; Zinman, Bernard; Baanstra, David; Pfarr, Egon; Schnaidt, Sven; Meinicke, Thomas; George, Jyothis T.; von Eynatten, Maximilian; Marx... Journal: Circulation Issue: Volume 139:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗